Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Efficacy of antiviral therapy with lamivudine after initial treatment for hepatitis B virus-related hepatocellular carcinoma.

Efficacy of antiviral therapy with lamivudine after initial treatment for hepatitis B virus-related hepatocellular carcinoma. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Efficacy of antiviral therapy with lamivudine after initial treatment for hepatitis B virus-related hepatocellular carcinoma. Abstract Text:

    teiji kuzuyaTeiji Kuzuya,yoshiaki katanoYoshiaki Katano,takashi kumadaTakashi Kumada,hidenori toyodaHidenori Toyoda,isao nakanoIsao Nakano,yoshiki hirookaYoshiki Hirooka,akihiro itohAkihiro Itoh,masatoshi ishigamiMasatoshi Ishigami,kazuhiko hayashiKazuhiko Hayashi,takashi hondaTakashi Honda,hidemi gotoHidemi Goto,teiji kuzuyaTeiji Kuzuya,yoshiaki katanoYoshiaki Katano,takashi kumadaTakashi Kumada,hidenori toyodaHidenori Toyoda,isao nakanoIsao Nakano,yoshiki hirookaYoshiki Hirooka,akihiro itohAkihiro Itoh,masatoshi ishigamiMasatoshi Ishigami,kazuhiko hayashiKazuhiko Hayashi,takashi hondaTakashi Honda,hidemi gotoHidemi Goto,

    AIM: The aim of this study was to determine whether antiviral therapy with lamivudine is beneficial in patients after initial treatment for hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC). METHODS: Forty-nine consecutive patients with HBV-related HCC completely treated by hepatic resection or radiofrequency ablation were retrospectively enrolled in this study. Comparison was made between 16 patients who received lamivudine therapy at a dose of 100 mg/day after treatment for HCC (lamivudine group) and 33 patients who did not (control group) in terms of changes in remnant liver function, HCC recurrence and survival. RESULTS: Cumulative recurrence rates of HCC did not significantly differ between the two groups (P = 0.622). However, median Child-Pugh score at the time of HCC recurrence was significantly different; 5 (range 5-6) in the lamivudine group versus 7 (range 5-12) in the control group (P = 0.005). All patients in the lamivudine group were able to receive curative treatment for recurrent HCC. In contrast, 10 of 15 patients in the control group were unable to receive curative optimal therapy for recurrent HCC due to deterioration of remnant liver function. The cumulative survival rates of patients in the lamivudine group tended to be higher than those of patients in the control group (P = 0.063). CONCLUSION: It is suggested that lamivudine therapy is beneficial for patients after initial treatment for HBV-related HCC because it contributes to improving remnant liver function, thus decreasing the risk of liver failure and increasing the chances of receiving available treatment modalities for recurrent HCC.

    Efficacy of antiviral therapy with lamivudine after initial treatment for hepatitis B virus-related hepatocellular carcinoma. Publishing Authors By Initials

    t kuzuyaT Kuzuya,y katanoY Katano,t kumadaT Kumada,h toyodaH Toyoda,i nakanoI Nakano,y hirookaY Hirooka,a itohA Itoh,m ishigamiM Ishigami,k hayashiK Hayashi,t hondaT Honda,h gotoH Goto,t kuzuyaT Kuzuya,y katanoY Katano,t kumadaT Kumada,h toyodaH Toyoda,i nakanoI Nakano,y hirookaY Hirooka,a itohA Itoh,m ishigamiM Ishigami,k hayashiK Hayashi,t hondaT Honda,h gotoH Goto,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Efficacy of antiviral therapy with lamivudine after initial treatment for hepatitis B virus-related hepatocellular carcinoma. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Journal of gastroenterology and hepatology

    VOLUME: 22

    Page Numbers: 1929-35

    Journal Abbreviation: J. Gastroenterol. Hepatol.

    ISSN: 0815-9319

    DAY: 4

    MONTH: Nov

    YEAR: 2007

    Efficacy of antiviral therapy with lamivudine after initial treatment for hepatitis B virus-related hepatocellular carcinoma. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 8607909

    Efficacy of antiviral therapy with lamivudine after initial treatment for hepatitis B virus-related hepatocellular carcinoma. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Efficacy of antiviral therapy with lamivudine after initial treatment for hepatitis B virus-related hepatocellular carcinoma. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Efficacy of antiviral therapy with lamivudine after initial treatment for hepatitis B virus-related hepatocellular carcinoma.

    AFFILIATION: Department of Gastroenterology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.

    Country: Australia

    Australia Research PublicationAustralia Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: J Gastroenterol Hepatol

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Efficacy of antiviral therapy with lamivudine after initial treatment for hepatitis B virus-related hepatocellular carcinoma Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News